Summary
Stryker Corporation (SYK) has filed an 8-K report detailing the resolution of a Dutch dividend withholding tax issue related to its acquisition of Wright Medical Group N.V. As a result of the acquisition's merger phase, a portion of the cash consideration ($1.85 per share) was withheld to cover potential Dutch Exit Tax. This tax was contingent on the enactment of a specific legislative proposal by January 1, 2022. As the legislative proposal was not enacted by the deadline, Stryker has instructed the paying agent to return the withheld Dutch Exit Tax Amount of $1.85 per share to the former Wright shareholders from whom it was originally deducted. This is a positive development for those former shareholders, as they will now receive the full intended merger consideration. Investors in Stryker should note this is primarily a resolution of a prior transaction detail and does not represent a new operational event for Stryker itself.
Key Highlights
- 1Stryker's 8-K filing addresses the Dutch Exit Tax related to the Wright Medical acquisition.
- 2A $1.85 per share cash amount was withheld from former Wright shareholders pending legislative action.
- 3The Dutch legislative proposal concerning the tax was not enacted by the January 1, 2022 deadline.
- 4Stryker has directed the paying agent to remit the $1.85 per share withheld amount back to former Wright shareholders.
- 5This action means former shareholders who had shares converted in the merger will receive the full cash consideration they were entitled to.
- 6The withheld amount was not applicable to shares purchased by Stryker during the tender offer phase.
- 7This filing provides finality on a post-acquisition tax matter for the company.